| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 31.98B | 39.17B | 40.59B | 34.41B | 41.18B | 21.98B |
| Gross Profit | 585.92M | 1.52B | 3.70B | 3.20B | 5.83B | 1.45B |
| EBITDA | 509.41M | 1.21B | 3.13B | 2.27B | 4.44B | 873.00M |
| Net Income | 274.91M | 921.53M | 2.12B | 1.67B | 3.46B | 462.36M |
Balance Sheet | ||||||
| Total Assets | 14.47B | 17.43B | 17.81B | 13.29B | 15.45B | 8.69B |
| Cash, Cash Equivalents and Short-Term Investments | 3.28B | 2.11B | 3.37B | 2.97B | 4.17B | 1.63B |
| Total Debt | 2.05B | 2.81B | 2.67B | 1.90B | 2.29B | 2.02B |
| Total Liabilities | 5.29B | 8.33B | 9.00B | 6.10B | 7.97B | 4.88B |
| Stockholders Equity | 8.79B | 8.66B | 8.49B | 6.92B | 7.23B | 3.93B |
Cash Flow | ||||||
| Free Cash Flow | 1.94B | -385.42M | 1.14B | 1.54B | 2.11B | 2.50B |
| Operating Cash Flow | 2.99B | 640.40M | 2.03B | 2.17B | 2.76B | 2.97B |
| Investing Cash Flow | -479.23M | -909.00M | -1.83B | -752.48M | -456.37M | -559.09M |
| Financing Cash Flow | -1.17B | -651.77M | 532.53M | -2.11B | 152.90M | -2.44B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
81 Outperform | HK$17.79B | 11.60 | 10.90% | 9.92% | -2.79% | -39.45% | |
74 Outperform | HK$1.12T | 13.10 | 12.82% | 8.97% | -13.87% | -15.41% | |
71 Outperform | HK$14.25B | 23.58 | 3.92% | 9.28% | -5.78% | -29.52% | |
65 Neutral | $15.17B | 7.61 | 4.09% | 5.20% | 3.87% | -62.32% | |
62 Neutral | HK$239.36B | 8.39 | 10.99% | 4.59% | -3.42% | -18.73% | |
56 Neutral | HK$2.17B | 4.52 | 3.21% | 20.68% | -23.72% | -86.69% | |
47 Neutral | HK$8.75B | -47.23 | 17.81% | 1.53% | -20.71% | 209.68% |